PCSA Price / Book | Processa Pharmaceuticals, Inc.

Processa Pharmaceuticals, Inc. (PCSA) Price / Book

2026-03-31: Price/Book Ratio 2.66.
2025-12-31: Price/Book Ratio 1.33.
2025-09-30: Price/Book Ratio 43.5.
2025-06-30: Price/Book Ratio 33.81.

Historical market capitalization divided by filed shareholder equity.

Available history: 2014-03-31 to 2026-03-31
Data captured: 2026-09-04

Historical Price/Book Ratio

Date	Price/Book Ratio
2026-03-31	2.66
2025-12-31	1.33
2025-09-30	43.5
2025-06-30	33.81
2025-03-31	13.82
2024-12-31	1.93
2024-09-30	30.07
2024-06-30	26.67
2024-03-31	19.01
2023-12-31	43.17
2023-09-30	429.55
2023-06-30	666.87
2023-03-31	604.69
2022-12-31	59.03
2022-09-30	1,041.85
2022-06-30	1,106.78
2022-03-31	1,025.76
2021-12-31	1,510.3
2021-09-30	2,456.67
2021-06-30	2,185.27
2021-03-31	2,699.53
2020-12-31	2,038.59
2020-09-30	5,163.45
2020-06-30	3,763.83
2020-03-31	3,792.11
2019-12-31	6,162.75
2019-09-30	40,306.1
2019-06-30	38,846.8
2019-03-31	37,090.01
2018-12-31	7,176.06
2018-09-30	56,045.97
2018-06-30	56,259.14
2018-03-31	74,313.11
2017-12-31	1,455,659.97
2015-03-31	634,645.89
2014-12-31	488,712.53
2014-06-30	781,850.25
2014-03-31	492,051.04

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
AMARIN CORP PLC\UK (AMRN)		$0.005B	-247.24
Xenetic Biosciences, Inc. (XBIO)	United States	$0.006B
ProPhase Labs, Inc. (PRPH)	United States	$0.006B	-0.06
Dermata Therapeutics, Inc. (DRMA)	United States	$0.005B	-0.62
REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH)	United States	$0.005B
Cadrenal Therapeutics, Inc. (CVKD)	United States	$0.004B	-0.90
Pulmatrix, Inc. (PULM)	United States	$0.006B
Lakewood-Amedex Biotherapeutics Inc. (LABT)	United States	$0.004B
Ernexa Therapeutics Inc. (ERNA)	United States	$0.006B
60 DEGREES PHARMACEUTICALS, INC. (SXTP)	United States	$0.004B	-0.59